Loading company…
Won 5 federal SBIR/STTR research awards from HHS and other federal agencies.
Boston Immune Technologies And Therapeutics Inc. has been awarded 5 US Small Business Innovation Research (SBIR/STTR) contracts totalling $6,819,314 between 2021 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in Winchester, Massachusetts.
6 rounds · latest SBIR Phase II award (HHS), Feb 2025
Sign in to see 6 rounds.
Sign inSign in to see 1 investors.
Sign inBoston Immune Technologies And Therapeutics Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Boston Immune Technologies And Therapeutics Inc..
Add diversity data